Retaglutide is a innovative GLP-1 receptor agonist currently under research for the treatment of type 2 diabetes. This medication works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://chiaraabgd953370.azzablog.com/39362275/semaglutide-a-potential-solution-for-diabetes